These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 7667719)

  • 1. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
    Myat-Phone-Kyaw ; Myint-Oo ; Aung-Naing ; Aye-Lwin-Htwe
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consideration of ethics in primaquine therapy against malaria transmission.
    Baird JK; Surjadjaja C
    Trends Parasitol; 2011 Jan; 27(1):11-6. PubMed ID: 20846906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
    Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory and field comparisons of adenosine influx in Plasmodium falciparum and Plasmodium vivax infected erythrocytes with genetic abnormalities from patients in Myanmar.
    Myint-Oo ; O'Sullivan WJ; Gero AM
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):22-31. PubMed ID: 9322280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
    Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F
    PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
    Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
    PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
    Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J
    Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
    Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment.
    Carmona-Fonseca J; Alvarez G; Maestre A
    Am J Trop Med Hyg; 2009 Feb; 80(2):188-93. PubMed ID: 19190211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
    Avalos S; Mejia RE; Banegas E; Salinas C; Gutierrez L; Fajardo M; Galo S; Pinto A; Mejia A; Fontecha G
    Malar J; 2018 Nov; 17(1):415. PubMed ID: 30409136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians.
    Louicharoen C; Patin E; Paul R; Nuchprayoon I; Witoonpanich B; Peerapittayamongkol C; Casademont I; Sura T; Laird NM; Singhasivanon P; Quintana-Murci L; Sakuntabhai A
    Science; 2009 Dec; 326(5959):1546-9. PubMed ID: 20007901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
    Oo NN; Bancone G; Maw LZ; Chowwiwat N; Bansil P; Domingo GJ; Htun MM; Thant KZ; Htut Y; Nosten F
    PLoS One; 2016; 11(4):e0152304. PubMed ID: 27035821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrence problems with preventive primaquine treatment in patients with malaria].
    Rønn AM; Bygbjerg IC
    Ugeskr Laeger; 1993 Nov; 155(48):3901-4. PubMed ID: 8273193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit.
    Jalloh A; Tantular IS; Pusarawati S; Kawilarang AP; Kerong H; Lin K; Ferreira MU; Matsuoka H; Arai M; Kita K; Kawamoto F
    Trop Med Int Health; 2004 May; 9(5):615-23. PubMed ID: 15117307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Widespread use of primaquine for control of Plasmodium vivax epidemics in a population with varying degrees of G6PD deficiency].
    Kondrashin AV; Baranova AM; Sergiev VP
    Med Parazitol (Mosk); 2010; (4):24-8. PubMed ID: 21400709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial.
    Taylor WR; Olupot-Olupot P; Onyamboko MA; Peerawaranun P; Weere W; Namayanja C; Onyas P; Titin H; Baseke J; Muhindo R; Kayembe DK; Ndjowo PO; Basara BB; Bongo GS; Okalebo CB; Abongo G; Uyoga S; Williams TN; Taya C; Dhorda M; Tarning J; Dondorp AM; Waithira N; Fanello C; Maitland K; Mukaka M; Day NJP
    Lancet Infect Dis; 2023 Apr; 23(4):471-483. PubMed ID: 36462528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
    Taylor WRJ; Meagher N; Ley B; Thriemer K; Bancone G; Satyagraha A; Assefa A; Chand K; Chau NH; Dhorda M; Degaga TS; Ekawati LL; Hailu A; Hasanzai MA; Naddim MN; Pasaribu AP; Rahim AG; Sutanto I; Thanh NV; Tuyet-Trinh NT; Waithira N; Woyessa A; Dondorp A; von Seidlein L; Simpson JA; White NJ; Baird JK; Day NP; Price RN
    PLoS Negl Trop Dis; 2023 Sep; 17(9):e0011522. PubMed ID: 37672548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
    Taylor WRJ; Kheng S; Muth S; Tor P; Kim S; Bjorge S; Topps N; Kosal K; Sothea K; Souy P; Char CM; Vanna C; Ly P; Khieu V; Christophel E; Kerleguer A; Pantaleo A; Mukaka M; Menard D; Baird JK
    J Infect Dis; 2019 Oct; 220(11):1750-1760. PubMed ID: 31549159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of methemoglobinemia and glucose-6-phosphate dehydrogenase deficiency in malaria patients treated with primaquine].
    Santana MS; da Rocha MA; Arcanjo AR; Sardinha JF; Alecrim WD; Alecrim Md
    Rev Soc Bras Med Trop; 2007; 40(5):533-6. PubMed ID: 17992408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.